Open AccessCentral hypothyroidism in a pediatric case of primary acute monoblastic leukemia with central nervous system infiltration
Author(s) -
Yuya Sato,
Satomi Koyama,
Shigeko Kuwashima,
Masana Kato,
Mayuko Okuya,
Keitaro Fukushima,
Hidemitsu Kurosawa,
Osamu Arisaka
Publication year - 2017
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000007329
Subject(s) - medicine , levothyroxine , central hypothyroidism , leukemia , endocrinology , central nervous system , thyroid , hormone , cytarabine , methotrexate , triiodothyronine , acute leukemia
Rationale: Central nervous system (CNS) leukemia is a frequent diagnosis in pediatric acute myeloblastic leukemia (AML) and includes neural symptoms. However, CNS leukemia is rarely associated with central hypsothyroidism. Patient concerns and diagnoses: A 2-year-old female with AML with MLL rearrangement presented with CNS infiltration. Laboratory tests suggested the presence of central hypothyroidism (thyroid-stimulating hormone [TSH]: 0.48 mIU/ml, normal range 0.7–6.4 mIU/ml; serum free thyroxine [FT4]: 0.62 ng/dl, normal range 0.8–2.2 ng/dl; free triiodothyronine: 1.57 pg/ml, normal range 2.7–5.6 pg/ml). Magnetic resonance imaging detected no lesions in the hypothalamus, pituitary, or thyroid. Interventions and outcomes: Levothyroxine (2.5 mg/kg/day) was administered together with chemotherapy and intrathecal injection of methotrexate, cytarabine, and hydrocortisone into the cerebrospinal fluid. The FT4 concentration increased after levothyroxine treatment, but later decreased after relapse of CNS leukemia. The TSH concentrations remained low. After remission of CNS leukemia, the TSH and FT4 concentrations quickly recovered to their normal ranges. Lessons: We believe that the CNS leukemia directly affected TSH and thyroid hormone secretion in our patient.